COUGH
Clinical trials for COUGH explained in plain language.
Never miss a new study
Get alerted when new COUGH trials appear
Sign up with your email to follow new studies for COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could quiet chronic cough that just Won't stop
Symptom relief OngoingThis phase 3 study tests an experimental drug called BLU-5937 (camlipixant) in about 975 adults with refractory chronic cough, including unexplained chronic cough. Participants receive either the drug or a placebo for 24 weeks, and researchers measure how much coughing decreases …
Matched conditions: COUGH
Phase: PHASE3 • Sponsor: Bellus Health Inc. - a GSK company • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New cough drug candidate camlipixant tested in healthy volunteers
Knowledge-focused TerminatedThis phase 1 study tests camlipixant, a potential treatment for chronic cough, in 28 healthy adults. Researchers want to see how the body absorbs and processes different versions of the drug, and how food affects it. The main goal is to check safety and tolerability while measuri…
Matched conditions: COUGH
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC